Sionna Therapeutics (SION) Income from Continuing Operations (2024 - 2026)
Quarterly results put Income from Continuing Operations at 26779000.0 for Q1 2026, down 60.75% from a year ago — trailing twelve months through Mar 2026 was 85807000.0 (down 28.01% YoY), and the annual figure for FY2025 was 75687000.0, down 21.32%.
Sionna Therapeutics has reported Income from Continuing Operations over the past 3 years, most recently at 26779000.0 for Q1 2026.
- Income from Continuing Operations reached 26779000.0 in Q1 2026 per SION's latest filing, down from 20440000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 8726000.0 in Q2 2024 and bottomed at 26779000.0 in Q1 2026.
- Median Income from Continuing Operations over the past 3 years was 18239000.0 (2025), compared with a mean of 18316888.89.
- Peak annual rise in Income from Continuing Operations hit 20.61% in 2025, while the deepest fall reached 109.02% in 2025.
- Over 3 years, Income from Continuing Operations stood at 16014000.0 in 2024, then fell by 27.64% to 20440000.0 in 2025, then tumbled by 31.01% to 26779000.0 in 2026.
- Business Quant data shows Income from Continuing Operations for SION at 26779000.0 in Q1 2026, 20440000.0 in Q4 2025, and 20349000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -8.50 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 727.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Sionna Therapeutics | 1.87 Bn | 1.87 Bn | - | -26.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.78 Mn |
| Dec 31, 2025 | -20.44 Mn |
| Sep 30, 2025 | -20.35 Mn |
| Jun 30, 2025 | -18.24 Mn |
| Mar 31, 2025 | -16.66 Mn |
| Dec 31, 2024 | -16.01 Mn |
| Sep 30, 2024 | -25.63 Mn |
| Jun 30, 2024 | -8.73 Mn |
| Mar 31, 2024 | -12.02 Mn |